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ABSTRACT  23 
Background 24 
Shiga-toxin E. coli infections remain a public health concern because of the severity of the 25 
gastrointestinal illness and associated complications. Transmission pathways are typically 26 
elucidated from outbreaks, with foodborne transmission the primary source. However, most 27 
STEC cases are sporadic. This systematic review aimed to identify the most common pathways 28 
for sporadic STEC transmission and quantify their importance.  29 
Methods 30 
We systematically reviewed epidemiological studies of sporadic (non-outbreak) STEC cases that 31 
investigated potential risk factors. Searches were run in Medline, EMBASE, and Scopus. 32 
Included studies needed to confirm STEC infection and investigate ≥20 cases.  33 
Results 34 
31 studies were included, of which 25 were case-control or case-case studies. 62.5% found 35 
consumption of undercooked/raw meat associated with STEC infection while 70.4% found 36 
contact with animals or their environment a risk factor. Random-effects meta-analysis provided 37 
pooled odds ratios and population attributable fraction (PAF). The PAF was 19% for 38 
undercooked/raw meat, followed by person to person transmission at 15%. Contact with animals 39 
and visiting farm environments had PAFs of 14% and 12% respectively. 40 
Conclusions 41 
Out of potential sources for STEC exposure, undercooked meat and contact with animals and 42 
their environment were the most frequently found transmission routes. Decreasing the chances of 43 
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acquiring the bacteria by these methods would additionally cut down on the other major 44 
transmission route, person-to-person spread.  45 
 46 
INTRODUCTION  47 
Shiga-toxin producing Escherichia coli (STEC) are a group of Gram-negative bacterial 48 
pathogens that exist as normal microbiota in ruminant animals, such as cows and sheep. STEC 49 
colonization does not produce symptoms in these animals, but can cause severe disease in 50 
humans.  Transmission pathways include faecal-oral, food-borne, environmental, and person to 51 
person. STEC are characterized by their ability to release shiga-toxin, which kills host cells in 52 
the intestine and can enter the bloodstream to affect other organs, such as the kidneys and brain.  53 
Most STEC infections are caused by  E. coli O157:H7, but over 100 different shiga-toxin 54 
producing E. coli serotypes are associated with human illness [1, 2].  STEC is associated with 55 
more severe disease and increased complications compared to other bacterial causes of 56 
gastroenteritis [3-5]. Cases typically present with abdominal cramps, vomiting, and/or diarrhea, 57 
which may progress to haemorrhagic colitis. About 30% of confirmed cases require 58 
hospitalization [6], and about 10% of cases progress to haemolytic uremic syndrome (HUS), 59 
characterized by anaemia, kidney failure, and low platelet counts [7].  60 
In outbreaks (groups of linked infections), most cases relate to contaminated food [8, 9]. 61 
However, sporadic cases comprise nearly 80% of reported STEC infections [10].  The only 62 
previous synthesis of evidence on sporadic cases (Strachan et al.) compared five different case-63 
control studies from the USA and UK between 1998 and 2004 [11]. Since 2004, screening for 64 
non-O157 has become more common. A comprehensive and updated review synthesizing 65 
sporadic STEC transmission is warranted, including studies since 2004 and enhanced 66 
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information about non-O157 infection. In order to gain an understanding about which pathways 67 
occur most often for sporadic STEC infections, a systematic review of larger (20+ cases) 68 
epidemiological studies investigating exposures and risk factors leading to sporadic STEC 69 
infections was performed. Identifying the most common pathways will aid in development of 70 
policies and procedures to help reduce the risk of STEC infection.  71 
 72 
METHODS  73 
Search Strategy and Inclusion Criteria 74 
 Medline, Scopus, and Embase databases were searched through February 19th 2016 with 75 
no restrictions on date or language. Search terms included: Bacterial- “STEC, EHEC, VTEC, 76 
O157, non-O157, shiga-toxin”; and Participants - “human”; Transmission - “transmission, risk 77 
factor, exposure, contamination, outbreak, sporadic, infection” (full search strategy for Medline 78 
given in Supplemental Appendix 1). Eight grey literature sources were searched (Supplemental 79 
Appendix 2); only the first 100 hits in grey literature were reviewed.  Bibliographies of included 80 
studies were also checked for further references.  81 
 STEC infections in humans needed to be confirmed by an approved laboratory method, 82 
including but not limited to directly finding the toxin in stool samples or amplifying either the 83 
stx1 or stx2 genes from samples via PCR [12]. Any epidemiological study, whether descriptive 84 
or analytical, was eligible as long as the focus was on sporadic STEC infections, with a 85 
minimum 20 cases to ensure that quantitative results could be extracted. Studies had to present 86 
potential transmission data, to identify likely sources of exposure. The protocol for this 87 
systematic review is on PROSPERO (registration number CRD42015027593) [13].  88 
Source Selection and Data Extraction 89 
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 All references were screened by title and abstract independently in duplicate by EK and 90 
JB. Full texts of not-excluded articles were read in duplicate to make further exclusions or 91 
confirm eligibility. Eligibility disagreements were resolved by discussion (EK and JB). Abstracts 92 
without full text, such as conference proceedings, were excluded.  93 
 Information extracted from all studies included bibliographic details, study location and 94 
time period, criteria used to confirm STEC infection, and ages of participants. For descriptive 95 
studies, exposures and the percentage of participants encountering that transmission pathway 96 
prior to illness were recorded. For epidemiological studies, the selection of both cases and 97 
controls and significant exposures, along with their effect measures and confidence intervals, 98 
were extracted. For all studies, elapsed time between infection and interview, interview methods, 99 
and transmission pathways covered in the interview or questionnaire were also recorded. Data 100 
were extracted by one reviewer into a standardized form and verified by a second reviewer. 101 
Articles not in English were extracted by only one reviewer.  102 
Quality Assessment 103 
Quality assessment for the studies was based on the Newcastle-Ottawa scale that was 104 
tailored to the potential biases that could exist in these specific study designs [14]. Studies were 105 
judged for quality across three categories: study design, comparability of controls, and data 106 
collection. Within each category, two to four features that could influence the validity or the 107 
generalisability of study results were graded on their risk of bias, as low, high, or unclear. The 108 
categories are described in Supplementary Appendix 3. Studies were then labelled as either of 109 
“acceptable” or “poor” quality depending on whether 50% or greater of the fields had “unclear” 110 
or “high” risk of bias. 111 
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Synthesis of Results 112 
 A table was created containing categories of common exposures, including food, animal 113 
contact, water, and other environmental transmission routes across all studies. Whether or not 114 
each study asked about a particular exposure was documented (Supplemental Table 1), with any 115 
statistically significant results from each study recorded. This let us calculate the percentage of 116 
studies finding a particular exposure significant (out of those that assessed that risk factor at all). 117 
If studies provided both univariate and adjusted estimates, the results of the adjusted effects were 118 
used to fill in the table. We were concerned that whether a risk factor was identified as 119 
significant might depend on whether the study was poor or acceptable quality; therefore, Stata 120 
was used to perform a t-test comparing the proportions of studies finding a risk factor associated 121 
with STEC infection between acceptable and low quality studies [15].  122 
Those categories where over 50% of the studies found that exposure as a risk factor for 123 
STEC infection were combined in a random effects meta-analysis using RevMan software [16, 124 
17]. Any available odds ratios were included regardless of significance or method used for 125 
analysis (univariate vs. adjusted). If a study provided effect estimates for several similar 126 
exposures within a category, the one most similar to those used in the other studies was used. 127 
EpiInfo 7 was used to calculate odds ratios when the information was available [18]. The 128 
combined odds ratios for these exposures were used to calculate the population attributable 129 
fraction (PAF) using the formula PAF = Pepooled * [(ORpooled - 1)/ORpooled] [19]. Pepooled, the 130 
proportion of exposed cases, was calculated using OpenMeta[Analyst][20].  To assess 131 




From the initial search and after duplicate removal, 5,952 studies were screened on title 134 
and abstract (Figure 1). The full texts of 51 studies were obtained and read. 29 studies met all 135 
inclusion criteria and were included in the review. Two studies were identified through a review 136 
of the bibliographies and a search of the grey literature, raising the total number of included 137 
studies to 31 (Table 1).  138 
Included studies were published between 1989-2015. Six were descriptive studies and 21 139 
were case-control studies. The remaining four were classified as case-case studies; three of these 140 
compared O157 to non-O157 infections while the final compared STEC infections to diarrheal 141 
controls. 13 studies came from North America, 15 from Europe, 2 from Argentina, and 2 studies 142 
from Australia or New Zealand. 17 studies investigated just E. coli O157 while 14 studies 143 
included other STEC serotypes. Four analysed HUS cases as opposed to the STEC + diarrhea 144 
case definition used for the other studies.  145 
All studies in this review identified patients from hospitals records or national 146 
surveillance schemes. After cases were determined, questionnaires were administered to 147 
determine likely routes of STEC infection. Of the 25 analytic studies, a majority (19) matched 148 
controls to the cases based on either age, gender or location; only 13 studies used matched 149 
analysis in calculating their results. Two studies did not present their results as an odds ratio but 150 
instead used χ2 analysis to determine association.  Additionally, 19 of the 25 analytic studies 151 
presented results of either adjusted univariate or multivariate analysis, helping to control for 152 
potential confounders.  153 
Quality Assessment 154 
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 Only 7 of the 31 studies received a poor quality rating; 6 of these were the descriptive 155 
studies since they received a high risk of bias in all categories concerning controls (Table 1, full 156 
analysis given in Supplemental Table 2). 12 of the 25 analytic studies were at low risk of bias for 157 
all methodological items, 19 of 25 for comparability of cases and controls, and four of 25 for 158 
exposure assessment. Two studies (Slutsker 1998 and Vaillant 2009) were at low risk of bias for 159 
all items assessed.  160 
Common Transmission Pathways among all studies 161 
 The possible transmission routes were grouped to create several categories of exposure. 162 
Before determining the most common transmission pathways, whether or not each study 163 
evaluated an exposure route was determined (Supplemental Table 2). All 31 studies assessed 164 
some form of beef or other meat in the diet and 27 included questions about farm visits and/or 165 
animal contact. All other categories included were investigated in at least two-thirds of the 166 
studies.  167 
 To determine the most common pathways of transmission, the percentage of studies 168 
which assessed that exposure that found it significantly associated with STEC infection was 169 
calculated (Table 2; additional results in Supplemental Tables 3A-C). The most common 170 
significant exposure was undercooked or raw meat, linked to STEC infection in 62.5% of 171 
studies. The next most frequent pathway was person-to-person transmission (12/21 or 57.1% of 172 
studies investigating it found it was a transmission route for STEC). The “combined animal 173 
contact” category was created to determine the number of studies that found any association with 174 
animals or their habitat as a potential source of STEC infection (since it may be difficult to 175 
differentiate whether or not the exposure occurred due to contact with the animal, its faeces, or 176 
its living environment). Combined thus, the percentage of studies finding animal contact a source 177 
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of infection was greater than the percentage of studies finding undercooked or raw meat as a 178 
source of infection (70.4% for animal contact vs. 62.5% for undercooked or raw meat).  179 
Sub-group analysis 180 
 To determine if study quality affected the results of the most commonly found pathways, 181 
the studies were split into their acceptable and low quality rating and the percentage of studies 182 
finding a specific risk factor as associated with STEC infection were recalculated for each group 183 
(see Table 3). The difference in proportion between the studies of different qualities was 184 
significant only for cooked beef and dairy, indicating that study quality does not greatly affect 185 
which of the transmission routes was found most often in the included studies. 186 
 Twenty-eight of the 31 studies came from one of four regions: USA, Canada, UK, and 187 
Europe. The percentage of studies finding a risk factor that was significantly associated with 188 
STEC infection was re-calculated for each of these regions to find geographic differences in the 189 
STEC transmission routes (Table 4; full break-down by region in Supplemental Table 4). A few 190 
trends were apparent. The UK had fewer studies finding undercooked or raw meat as a risk 191 
factor for STEC infection while also having the highest percentage of combined animal contact. 192 
This suggests that environmental exposures play a larger role in the UK compared to other 193 
regions. Furthermore, both European and the UK combined animal contact was high compared 194 
to North America, indicating that acquiring STEC from contact with animals or their living 195 
environment may be more important for UK/Europe. 196 
 Six studies split their analyses to determine risk factors for O157 and non-O157 197 
separately. Out of all the exposure categories previously used in Table 2, only two, undercooked 198 
or raw meat and animal contact, had at least three of the 6 studies reporting odds ratios for either 199 
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O157 or non-O157 (Table 5). Five out of the 6 studies found that consuming or handling 200 
undercooked or raw meat was a risk factor for acquiring O157; none of these studies found this 201 
exposure associated with non-O157. Three out of 6 studies found that infection via animal 202 
contact was associated with non-O157 strains; only one study found the opposite with more 203 
O157 cases reporting contact with animals.  204 
Meta-analyses 205 
 Where ≥50% of the studies identified a particular risk factor as significant (Table 2), 206 
available data were combined in meta-analysis. Forest plots were created for undercooked or raw 207 
meat (Figure 2), farm visits (Figure 3), animal contact (Figure 4), and person-to-person 208 
transmission (Figure 5); details on the exposure investigated in each study is given in 209 
Supplemental Appendix 4A-D.  210 
 20 case-control studies reporting odds ratios asked about the consumption or handling of 211 
undercooked or raw meat; information useful for meta-analysis could be extracted from 17 of 212 
these studies (Figure 2). The combined odds ratio was 3.08 (95% CI: 1.9, 4.99). Heterogeneity 213 
was high with an I2 score of 86%. To calculate the population attributable fraction (PAF) of 214 
STEC infection for undercooked or raw meat, the proportion of exposed cases was calculated for 215 
each study; information was not available for two of the 18 included in the meta-analysis. This 216 
information was used to generate a pooled proportion of exposed cases; this and the pooled odds 217 
ratio were used to calculate a PAF of 19% (95% CI: 13-22%) (Table 6).  218 
 14 studies assessed living on or visiting a farm; information for meta-analysis was not 219 
available for three of these (Figure 3). The combined odds ratio for visiting a farm was 2.6 (95% 220 
CI: 2.11-3.21). Heterogeneity for this risk factor was very low (I2 = 0%). To calculate the PAF, 221 
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information from only one study was not available out of the 11 used to generate the summary 222 
odds ratio, providing a combined population attributable factor for farm visits of 12% (95% CI: 223 
10-13%). 224 
 18 studies provided odds ratios for contact with ruminant animals; the odds ratio was not 225 
available from six of these. The combined odds ratio was 3.02 (95% CI: 2.2-4.16) (Figure 4), 226 
with moderate heterogeneity (I2 = 38%).  For animal contact, information on the number of 227 
exposed cases was available for all 12 studies used in the meta-analysis; resulting in a combined 228 
PAF of 14% (95% CI: 11-15%). 229 
 15 studies appropriate for meta-analysis investigated some form of person-to-person 230 
transmission; odds ratios were available for 11 of these. The pooled odds ratio was 2.86 (95% 231 
CI: 1.69-4.84) (Figure 5), with high heterogeneity (I2 = 68%). The number of exposed 232 
individuals was available from ten of 11 studies, and the summary PAF was 15% (95% CI: 10-233 
19%).  234 
 The funnel plots of the studies for all four subgroups was not symmetric around the 235 
average value, indicating publication bias in the reported results (bias towards positive 236 
correlation: studies that looked for this factor but did not find it significant are underrepresented, 237 
see Figure 6) [21, 22]. What is missing in each plot are studies with high standard errors and 238 
effect estimates lower than the group average. To determine whether the publication bias 239 
affected overall conclusions, a subgroup analysis was performed [23]. The half of the studies 240 
with the largest standard errors were dropped since they represent the smaller studies and the 241 
meta-analyses run again with only the studies with lower standard errors. For all four risk 242 
factors, the odds ratio dropped but remained significantly associated with the exposure (95% CIs 243 
above one; see Table 7). Additionally, three of the four funnel plots were more symmetrical 244 
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around the pooled odds ratio; only person-to-person transmission still demonstrated evidence of 245 
publication bias similar to that which existed before the subgroup analysis was performed 246 
(Figure 7).  247 
DISCUSSION 248 
Using data from large case-control or surveillance studies, this review identified and 249 
quantified transmission pathways most commonly associated with sporadic STEC infections 250 
(about 80% of STEC infections). We included 31 studies from four continents, most of which 251 
(24 of 31) had acceptable quality. Two-thirds of the studies included in this systematic review 252 
found undercooked ground beef or other meat to be a significant risk factor for acquiring STEC. 253 
Where any type of contact with animals, their living environment or their manure were 254 
considered together.  Animal contact was identified more often than undercooked/raw meat as a 255 
potential source of STEC.  256 
 Several intriguing results were highlighted by our subgroup analyses. First was the 257 
potential difference in the most common STEC transmission pathways between Europe and 258 
North America. All the studies from the UK identified some form of animal contact as a source 259 
of STEC and had the lowest reported associations with STEC coming from undercooked or raw 260 
meat. While continental Europe found undercooked or raw meat significantly associated with 261 
STEC as frequently as North America, the European studies also found higher rates of infection 262 
from animal contact. The reasons behind these differences are not immediately apparent but 263 
suggests different regions may need to focus on different prevention methods to most efficiently 264 
reduce the number of STEC cases. Our results also indicate that infections from undercooked or 265 
raw meat occur most often because of O157 strains while non-O157 is more often associated 266 
with animal contact. Possible hypotheses for this are variations in environmental preferences of 267 
13 
 
different E. coli serotypes or O157 having a lower infectious dose. Little research has been done 268 
into the survival or infectious dose of non-O157 strains, but initial studies suggest little 269 
difference between O157 and the few non-O157 serotypes tested [24-29]. Still, given the large 270 
number of STEC serotypes that can cause infections in humans, more research needs to be 271 
performed to help address these issues. 272 
 Of the individual risk factors, preventing infections from undercooked or ground beef 273 
would cause the greatest single reduction in disease, with a PAF of 19% (although this, and the 274 
other PAFs, may have been distorted by publication bias).  Our review estimates that 15% of 275 
STEC infections could be prevented if transmission no longer occurred via person-to-person 276 
contact.  PAFs for farm visits and animal contact were 12% and 14%, respectively. It could be 277 
argued that because the PAFs from all four risk factors are similar, intervention strategies should 278 
target multiple transmission pathways to make major impacts.  279 
Many attributes of the primary research data may limit our results. Exclusion criteria 280 
(such as history of diarrhea in cases or controls) were applied inconsistently between studies.  281 
Furthermore, each study asked about a slightly different exposure duration. Most studies asked 282 
about 1-2 weeks prior to the onset of symptoms, but the full relevant exposure period range is 5-283 
30 days prior to infection. Shorter timeframes may have missed potential sources of infection 284 
while longer ones possibly recorded many exposures that were not relevant. While the 285 
geographical subgroup analyses revealed interesting trends, there were few studies (6 to 8) in 286 
each group. Only a small number of studies (n=6) included exposure to both O157 and non-287 
O157.  Some studies could not be included in meta-analyses as information was missing, 288 
possibly because calculated odds ratios were not statistically significant and therefore not 289 
reported. This, along with the likely publication bias, suggests that our summary odds ratios, and 290 
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the PAFs based on them, are overestimated. However, the odds ratios obtained after our 291 
sensitivity analysis indicate that these four transmission routes are definitely associated with 292 
sporadic STEC infections. 293 
 In summary, by combining the results from 31 studies, this systematic review identified 294 
the most common transmission pathways for sporadic STEC infections. These included 295 
consuming undercooked meat, contact with animals or their environment, and person-to-person 296 
transmission after contact with someone with diarrhea. One caveat to the reported odds ratios 297 
and PAF values is combining the data from all available published studies. Our subgroup 298 
analysis by region suggests that different pathways play more predominant roles in different 299 
areas. This, combined with the fact that STEC incidence rates vary by country, indicates that 300 
case-control studies need to be performed to identify the best prevention strategies for each 301 
country.  302 
Acknowledgements 303 
The authors would like to thank Johanna Nader for help in translating studies.  304 
Funding 305 
This work was supported by the National Institute for Health Research Health Protection 306 
Research Unit in Gastrointestinal Infections. 307 
Disclaimer 308 
The research was funded by the National Institute for Health Research Health Protection 309 
Research Unit (NIHR HPRU) in Gastrointestinal Infections at the University of Liverpool in 310 
partnership with Public Health England (PHE), University of East Anglia, University of Oxford 311 
15 
 
and the Institute of Food Research. Erica Kintz, Lee Hooper and Paul Hunter are based at the 312 
University of East Anglia. The views expressed are those of the author(s) and not necessarily 313 
those of the NHS, the NIHR, the Department of Health or Public Health England. 314 
Conflict of Interest 315 
The authors declare no conflicts of interest in completing this work. 316 
References 317 
1. Organization WH. Report of the WHO Working Group Meeting on Shiga-Like Toxin Producing 318 
Escherichia Coli (SLTEC) with Emphasis on Zoonotic Aspects, Bergamo, Italy, 1 July 1994. 1995. 319 
2. Caprioli A, Morabito S, Brugère H, Oswald E. Enterohaemorrhagic Escherichia coli: emerging 320 
issues on virulence and modes of transmission. Vet Res 2005; 36(3): 289-311. 321 
3. Hall G, Yohannes K, Raupach J, Becker N, Kirk M. Estimating community incidence of Salmonella, 322 
Campylobacter, and Shiga toxin-producing Escherichia coli infections, Australia. Emerging 323 
infectious diseases 2008; 14(10): 1601-9. 324 
4. Tam CC, Rodrigues LC, Viviani L, et al. Longitudinal study of infectious intestinal disease in the UK 325 
(IID2 study): incidence in the community and presenting to general practice. Gut 2012; 61(1): 326 
69-77. 327 
5. Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States--major 328 
pathogens. Emerging infectious diseases 2011; 17(1): 7-15. 329 
6. Byrne L, Jenkins C, Launders N, Elson R, Adak GK. The epidemiology, microbiology and clinical 330 
impact of Shiga toxin-producing Escherichia coli in England, 2009-2012. Epidemiology and 331 
infection 2015: 1-13. 332 
7. Gould LH, Demma L, Jones TF, et al. Hemolytic uremic syndrome and death in persons with 333 
Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-334 
2006. Clinical Infectious Diseases 2009; 49(10): 1480-5. 335 
8. Heiman KE, Mody RK, Johnson SD, Griffin PM, Gould LH. Escherichia coli O157 Outbreaks in the 336 
United States, 2003-2012. Emerging infectious diseases 2015; 21(8): 1293-301. 337 
9. Adams NL, Byrne L, Smith GA, et al. Shiga Toxin-Producing Escherichia coli O157, England and 338 
Wales, 1983-2012. Emerging infectious diseases 2016; 22(4): 590-7. 339 
10. Thomas A, Cheasty T, Frost JA, Chart H, Smith HR, Rowe B. Vero cytotoxin-producing Escherichia 340 
coli, particularly serogroup O157, associated with human infections in England and Wales: 1992-341 
4. Epidemiology and infection 1996; 117(1): 1-10. 342 
11. Strachan NJ, Dunn GM, Locking ME, Reid TM, Ogden ID. Escherichia coli O157: burger bug or 343 
environmental pathogen? International Journal of Food Microbiology 2006; 112(2): 129-37. 344 
12. Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB. Recent advances in 345 
understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev 2013; 26(4): 822-80. 346 
13. Kintz E BJ, Hooper L, Hunter P. Identification of risk factors for Shiga-toxin producing E. coli 347 
infections: a systematic review. PROSPERO: International prospective register of systematic 348 




14. Wells GA SB, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale 351 
(NOS) for assessing the quality if nonrandomized studies in meta-analyses. 352 
15. StataCorp. Stata Statisical Software: Release 13. College Station, TX: StataCorp LP 2013. 353 
16. Hedges LV, Vevea JL. Fixed- and random-effects models in meta-analysis. Psychol Methods 354 
1998; 3(4): 486-504. 355 
17. Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic 356 
Cochrane Centre TCC, 2014. 357 
18. Dean AG AT, Sunki GG, Friedman R,, Lantinga M SS, Zubieta JC, Sullivan KM, Brendel KA, Gao Z,, 358 
Fontaine N SM, Fuller G, Smith DC, Nitschke DA, and Fagan RF. . Epi Info™, a database and 359 
statistics program for public health professionals. CDC 2011. 360 
19. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J 361 
Public Health 1998; 88(1): 15-9. 362 
20. Wallace BC, Issa J. Dahabreh, Thomas A. Trikalinos, Joseph Lau, Paul Trow, and Christopher H. 363 
Schmid. Closing the Gap between Methodologists and End-Users: R as a Computational Back-364 
End. Journal of Statistical Software 2012. 365 
21. Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel 366 
plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011; 343: d4002. 367 
22. Song F, Parekh S, Hooper L, et al. Dissemination and publication of research findings: an updated 368 
review of related biases. Health technology assessment 2010; 14(8): iii, ix-xi, 1-193. 369 
23. Higgins JPT GSe. Cochrane Handbook for Systematic Reviews of Interventions. 2011; Version 370 
5.1.0 [updated March 2011]. 371 
24. Berry ED, Barkocy-Gallagher GA, Siragusa GR. Stationary-phase acid resistance and injury of 372 
recent bovine Escherichia coli O157 and non-O157 biotype I Escherichia coli isolatest. Journal of 373 
food protection 2004; 67(3): 583-90. 374 
25. Buvens G, Posse B, De Schrijver K, De Zutter L, Lauwers S, Pierard D. Virulence profiling and 375 
quantification of verocytotoxin-producing Escherichia coli O145:H28 and O26:H11 isolated 376 
during an ice cream-related hemolytic uremic syndrome outbreak. Foodborne pathogens and 377 
disease 2011; 8(3): 421-6. 378 
26. Duffy G, Walsh C, Blair IS, McDowell DA. Survival of antibiotic resistant and antibiotic sensitive 379 
strains of E. coli O157 and E. coli O26 in food matrices. Int J Food Microbiol 2006; 109(3): 179-380 
86. 381 
27. Large TM, Walk ST, Whittam TS. Variation in acid resistance among shiga toxin-producing clones 382 
of pathogenic Escherichia coli. Applied and environmental microbiology 2005; 71(5): 2493-500. 383 
28. Luchansky JB, Porto-Fett AC, Shoyer BA, et al. Fate of Shiga toxin-producing O157:H7 and non-384 
O157:H7 Escherichia coli cells within blade-tenderized beef steaks after cooking on a 385 
commercial open-flame gas grill. Journal of food protection 2012; 75(1): 62-70. 386 
29. Paton AW, Ratcliff RM, Doyle RM, et al. Molecular microbiological investigation of an outbreak 387 
of hemolytic-uremic syndrome caused by dry fermented sausage contaminated with Shiga-like 388 
toxin-producing Escherichia coli. Journal of clinical microbiology 1996; 34(7): 1622-7. 389 
30. Bryant HE, Athar MA, Pai CH. Risk factors for Escherichia coli O157:H7 infection in an urban 390 
community. The Journal of infectious diseases 1989; 160(5): 858-64. 391 
31. Byrne L, Vanstone GL, Perry NT, et al. Epidemiology and microbiology of Shiga toxin-producing 392 
Escherichia coli other than serogroup O157 in England, 2009-2013. Journal of medical 393 
microbiology 2014; 63(Pt 9): 1181-8. 394 
32. Byrne L, Jenkins C, Launders N, Elson R, Adak GK. The epidemiology, microbiology and clinical 395 
impact of Shiga toxin-producing Escherichia coli in England, 2009-2012. Epidemiology and 396 
infection 2015; 143(16): 3475-87. 397 
17 
 
33. Coia JE, Sharp JCM, Campbell DM, Curnow J, Ramsay CN. Environmental risk factors for sporadic 398 
Escherichia coli O157 infection in Scotland: Results of a descriptive epidemiology study. J 399 
Infection 1998; 36(3): 317-21. 400 
34. Denno DM, Keene WE, Hutter CM, et al. Tri-county comprehensive assessment of risk factors for 401 
sporadic reportable bacterial enteric infection in children. The Journal of infectious diseases 402 
2009; 199(4): 467-76. 403 
35. Eklund M, Nuorti JP, Ruutu P, Siitonen A. Shigatoxigenic Escherichia coli (STEC) infections in 404 
Finland during 1998-2002: a population-based surveillance study. Epidemiology and infection 405 
2005; 133(5): 845-52. 406 
36. Friesema IH, Schotsborg M, Heck ME, Van Pelt W. Risk factors for sporadic Shiga toxin-producing 407 
Escherichia coli O157 and non-O157 illness in The Netherlands, 2008-2012, using periodically 408 
surveyed controls. Epidemiology and infection 2015; 143(7): 1360-7. 409 
37. Gianviti A, Rosmini F, Caprioli A, et al. Haemolytic-uraemic syndrome in childhood: surveillance 410 
and case-control studies in Italy. Italian HUS Study Group. Pediatric nephrology (Berlin, 411 
Germany) 1994; 8(6): 705-9. 412 
38. Holton D, Wilson J, Ellis A, et al. A Canadian multicentre case-control study of sporadic 413 
Escherichia coli 0157:H7 infection. Can J Infect Dis 1999; 10(2): 117-21. 414 
39. Huber HC, Kugler R, Liebl B. [Infections with enterohemorrhagic Escherichia coli (EHEC)--results 415 
of an epidemiologic survey in Bavaria for the April 1996 to May 1997 time frame]. 416 
Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 417 
1998; 60(3): 159-65. 418 
40. Jaros P, Cookson AL, Campbell DM, et al. A prospective case-control and molecular 419 
epidemiological study of human cases of Shiga toxin-producing Escherichia coli in New Zealand. 420 
BMC infectious diseases 2013; 13: 450. 421 
41. Kassenborg HD, Hedberg CW, Hoekstra M, et al. Farm visits and undercooked hamburgers as 422 
major risk factors for sporadic Escherichia coli O157:H7 infection: data from a case-control study 423 
in 5 FoodNet sites. Clinical infectious diseases : an official publication of the Infectious Diseases 424 
Society of America 2004; 38 Suppl 3: S271-8. 425 
42. Le Saux N, Spika JS, Friesen B, et al. Ground beef consumption in noncommercial settings is a 426 
risk factor for sporadic Escherichia coli O157:H7 infection in Canada. The Journal of infectious 427 
diseases 1993; 167(2): 500-2. 428 
43. Locking ME, O'Brien SJ, Reilly WJ, et al. Risk factors for sporadic cases of Escherichia coli O157 429 
infection: the importance of contact with animal excreta. Epidemiology and infection 2001; 430 
127(2): 215-20. 431 
44. MacDonald KL, O'Leary MJ, Cohen ML, et al. Escherichia coli O157:H7, an emerging 432 
gastrointestinal pathogen. Results of a one-year, prospective, population-based study. Jama 433 
1988; 259(24): 3567-70. 434 
45. McPherson M, Lalor K, Combs B, Raupach J, Stafford R, Kirk MD. Serogroup-specific risk factors 435 
for Shiga toxin-producing Escherichia coli infection in Australia. Clinical infectious diseases : an 436 
official publication of the Infectious Diseases Society of America 2009; 49(2): 249-56. 437 
46. Mead PS, Finelli L, Lambert-Fair MA, et al. Risk factors for sporadic infection with Escherichia coli 438 
O157:H7. Archives of internal medicine 1997; 157(2): 204-8. 439 
47. O'Brien SJ, Adak GK, Gilham C. Contact with farming environment as a major risk factor for Shiga 440 
toxin (Vero cytotoxin)-producing Escherichia coli O157 infection in humans. Emerging infectious 441 
diseases 2001; 7(6): 1049-51. 442 
48. Parry SM, Salmon RL, Willshaw GA, Cheasty T. Risk factors for and prevention of sporadic 443 
infections with vero cytotoxin (shiga toxin) producing Escherichia coli O157. Lancet 1998; 444 
351(9108): 1019-22. 445 
18 
 
49. Pierard D, Crowcroft N, De Bock S, et al. A case-control study of sporadic infection with O157 446 
and non-O157 verocytotoxin-producing Escherichia coli. Epidemiology and infection 1999; 447 
122(3): 359-65. 448 
50. Proctor ME, Davis JP. Escherichia coli O157:H7 infections in Wisconsin, 1992-1999. WMJ 2000; 449 
99(5): 32-7. 450 
51. Rivas M, Sosa-Estani S, Rangel J, et al. Risk factors for sporadic Shiga toxin-producing Escherichia 451 
coli infections in children, Argentina. Emerging infectious diseases 2008; 14(5): 763-71. 452 
52. Rivero MA, Passucci JA, Rodriguez EM, Signorini ML, Tarabla HD, Parma AE. Factors associated 453 
with sporadic verotoxigenic Escherichia coli infection in children with diarrhea from the Central 454 
Eastern Area of Argentina. Foodborne pathogens and disease 2011; 8(8): 901-6. 455 
53. Rowe PC, Orrbine E, Lior H, Wells GA, McLaine PN. Diarrhoea in close contacts as a risk factor for 456 
childhood haemolytic uraemic syndrome. The CPKDRC co-investigators. Epidemiology and 457 
infection 1993; 110(1): 9-16. 458 
54. Slutsker L, Ries AA, Maloney K, Wells JG, Greene KD, Griffin PM. A nationwide case-control study 459 
of Escherichia coli O157:H7 infection in the United States. The Journal of infectious diseases 460 
1998; 177(4): 962-6. 461 
55. Vaillant V, Espie E, de Valk H, et al. Undercooked ground beef and person-to-person 462 
transmission as major risk factors for sporadic hemolytic uremic syndrome related to Shiga-toxin 463 
producing Escherchia coli infections in children in France. The Pediatric infectious disease 464 
journal 2009; 28(7): 650-3. 465 
56. Van Duynhoven YT, De Jager CM, Heuvelink AE, et al. Enhanced laboratory-based surveillance of 466 
Shiga-toxin-producing Escherichia coli O157 in The Netherlands. European journal of clinical 467 
microbiology & infectious diseases : official publication of the European Society of Clinical 468 
Microbiology 2002; 21(7): 513-22. 469 
57. Voetsch AC, Kennedy MH, Keene WE, et al. Risk factors for sporadic Shiga toxin-producing 470 
Escherichia coli O157 infections in FoodNet sites, 1999-2000. Epidemiology and infection 2007; 471 
135(6): 993-1000. 472 
58. Wang X, Taylor M, Hoang L, et al. Comparison of clinical and epidemiological features of Shiga 473 
toxin-producing Escherichia coli O157 and non-O157 infections in British Columbia, 2009 to 474 
2011. The Canadian journal of infectious diseases & medical microbiology = Journal canadien 475 
des maladies infectieuses et de la microbiologie medicale / AMMI Canada 2013; 24(4): e102-6. 476 
59. Waters JR, Sharp JC, Dev VJ. Infection caused by Escherichia coli O157:H7 in Alberta, Canada, 477 
and in Scotland: a five-year review, 1987-1991. Clinical infectious diseases : an official 478 
publication of the Infectious Diseases Society of America 1994; 19(5): 834-43. 479 
60. Werber D, Behnke SC, Fruth A, et al. Shiga toxin-producing Escherichia coli infection in Germany: 480 






Table 1: Characteristics of Included Studies 485 
Reference Study Dates Country Design Outcome/STEC # cases/controls Qualitya 
Bryant et al. 
1989 [30] 
Summers 1986 & 
1987 
Canada Case-control Diarrhea/O157 Diarrhea control: 
52 per group 
Community 
control: 49 per 
group 
acceptable 
Byrne et al. 2014 
[31] 




2300 O157 / 
67 Non O 157 
acceptable 
Byrne et al. 2015 
[32] 
2009-2012 England Otherb Diarrhea/all 1772 cases acceptable 




Scotland Descriptive Diarrhea/O157 138 cases poor 




United States Case-control Diarrhea/O157 39 cases/ 
78 controls 
acceptable 
Eklund et al. 
2005 [35] 
1998-2002 Finland Descriptive Diarrhea/all 26 O157/27 non poor 
Friesema et al. 
2015 [36] 
2008-2012 Netherlands Case-control Diarrhea/all 130 O157/ 
78 non O157/ 
1563 controls 
poor 
Gianviti et al. 
1994 [37] 




HUS/all 43 cases/ 
43 controls 
acceptable 






Diarrhea/O157 100 cases/ 
200 controls 
acceptable 
Huber et al. 1998 
[39] 
April 1996 – 
March 1997 
Germany Descriptive Diarrhea/all 300 cases acceptable 
Jaros et al. 2013 
and Jaros 2014c 
[40] 
July 2011-2012  New Zealand Case-control Diarrhea/all 113 cases/ 
506 controls 
acceptable 
Kassenborg et al. 
2004 [41] 
March 1996 – 
April 1997 
United States Matched Case-
control 
Diarrhea/O157 196 cases/ 
372 controls 
acceptable 

















Diarrhea/O157 183 cases/ 
545 controls 
acceptable 
MacDonald et al. 
1988 [44] 
May 1985 – 
April 1986 
United States Case-control Diarrhea/O157 24 cases/ 
48 controls 
acceptable 
McPherson et al. 
2009 [45] 
July 2003 –  
April 2007 
Australia Case-control Diarrhea/all 113 cases/ 
304 controls 
acceptable 
Mead et al. 1997 
[46] 
July 1994 United States Matched Case-
control 
Diarrhea/O157 23 cases/ 
46 controls 
poor 




England Case-control Diarrhea/O157 369 cases/ 
511 controls 
acceptable 








Diarrhea/O157 85 cases/ 
142 controls 
acceptable 
Pierard et al. 
1999 [49] 
Unclear Belgium Matched Case-
control 
Diarrhea/all 37 cases/ 
69 controls 
acceptable 
Proctor et al. 
2000 [50] 
1992-1999 United States Descriptive Diarrhea/O157 994 cases poor 
Rivas et al. 2008 
[51] 
2001-2002 Argentina Matched Case-
control 
Diarrhea/all 150 cases/ 
300 controls 
acceptable 
Rivero et al. 
2011 [52] 
December 2002 – 
April 2009 
Argentina Case-case Diarrhea/all 63 cases/ 
374 controls 
acceptable 
Rowe et al. 1993 
[53] 
May-August 1990 Canada Case-control HUS/O157 34 cases/ 
102 controls 
acceptable 
Slutsker et al. 
1998 [54] 
October 1990-1992 United States Matched Case-
control 
Diarrhea/O157 73 cases/ 
142 controls 
acceptable 
Vaillant et al. 
2009 [55] 
2000-2001 France Matched Case-
control 




et al. 2002 [56] 
January 1999 –  
June 2001 
Netherlands Descriptive Diarrhea/O157 82 cases poor 
Voestch et al. 
2006 [57] 
1999-2000 United States Case-Control Diarrhea/O157 283 cases/ 
534 controls 
acceptable 
Wang et al. 2013 
[58] 
2009-2011 Canada Case-case Diarrhea/all 154 O157/ 
63 non O157 
acceptable 
Waters et al. 
1994 [59] 
1987-1991 Canada Descriptive Diarrhea/O157 1484 cases poor 
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a: refer to text and Supplemental Appendix 3 for determination of quality 486 
b: categorical χ2 analysis based on national surveillance data 487 
d: Dissertation thesis “Epidemiological investigations of STEC O157 and O26 in New Zealand slaughter cattle, and the source attribution of 488 

















  1987-1991 Scotland Descriptive Diarrhea/O157 505 cases  




Germany Matched Case 
control 
Diarrhea/all 29 O157/ 





Table 2: Results of Systematic Review with exposures split into general categories 506 
 



























# studies finding RFa 
significant 
20 7 8 8 2 10 13 6 19 8 8 6 12 
# asking about RF 32 31 29 24 24 19 24 15 27 21 20 21 21 
Percentage 62.5% 22.6% 27.6% 33.3% 8.3% 52.6% 54.2% 40% 70.4% 38.1% 40% 28.6% 57.1% 
















Table 3: Study quality does not affect the proportion of studies finding different risk factors as associated with STEC infections 521 
 





























63.6% 12.5% 31.8% 22.2% 12.5% 50% 45% 45.5% 66.7% 29.4% 40% 23.5% 53.3% 
low quality studies 75% 57.1% 14.3% 66.7% 0% 60% 75% 25% 83.3% 75% 40% 23.5% 66.7% 

















Table 4: Percentage of studies from different regions finding different risk factors significant 536 
 Undercooked or Raw Meat Animal Contact: Combined Person-to-person 
USA 71.43% 42.876% 66.67% 
Canada 66.67% 33.33% 100% 
UK 50% 100% 50% 




















Table 5: Odds ratios separated by STEC serogroup 554 
Study Pink or Raw Meata Animal Contact 
Byrne 2014 O157 8.05 [1.11, 58.30] NON 3.3 [1.69, 6.40] 
Friesema 2015 (< 10 yrs) O157 9.97 [2.29, 43.38] NON 5.8 [1.10, 30.75] 
Friesema 2015 (> 10 yrs) O157 2.10 [1.26, 3.50] -b 
McPherson 2009 O157 4.57 [1.42, 14.70] NON 5.0 [2.09, 11.99] 
Rivas 2008 O157 17.64 [3.08, 100.92] O157 6.6c 
Wang 2013 - b -b 
a: odds ratio given 555 
b: no associated risk factor found 556 

















Table 6: Population attributable fractions for risk factors included in meta-analysis 572 
Exposure Pepooled ORpooleda PAFa 
Pink or Raw Meat 0.279 3.08 [1.9, 4.99] 0.19 [0.13, 0.22] 
Farm Visits 0.19 2.6 [2.11, 2.31] 0.12 [0.10, 0.13] 
Animal Contact 0.204 3.02 [2.2, 4.16] 0.14 [0.11, 0.15] 
Person-to-person 0.236 2.86 [1.69, 4.84] 0.15 [0.10, 0.19] 













Table 7: Odds ratios after sugroup analysis 584 
Exposure ORpooleda 
Pink or Raw Meat 2.07 [1.22, 3.51] 
Farm Visits 2.48 [1.99, 3.09] 
Animal Contact 2.5 [1.72, 3.62] 
Person-to-person 2.0 [1.14, 3.5] 









Figure Legends 592 
Figure 1: PRISMA flow diagram of included studies. 593 
 594 
Figure 2: Meta-analysis of undercooked or raw meat. 595 
For Werber, exposure to undercooked or raw meat was only significant in age groups over 10 596 
years old. For Friesema, those under 10 had an OR of 10 (2.3-43.5), but this was not included in 597 
the meta-analysis to prevent over-representation of this study in the results. * OR was adjusted 598 
for possible confounders. “Not estimable” means no data relevant to this risk-factor could be 599 
extracted.  600 
 601 
Figure 3: Meta-analysis of farm visits. 602 
This risk factor was only significant in the Kassenborg study for children under 6 years old. The 603 
Werber study values were calculated using EpiInfo from data provided in the manuscript. * OR 604 
was adjusted for possible confounders. “Not estimable” means no data relevant to this risk-factor 605 
could be extracted. 606 
 607 
Figure 4: Meta-analysis for animal contact. 608 
For Friesema, animal contact was only significant for non-O157 and cases under 10 years old. 609 
Similarly, Weber found this risk factor significant for those under three years old. Kassenborg 610 
found it significant for those over 6 years of age. * OR was adjusted for possible confounders. 611 
“Not estimable” means no data relevant to this risk-factor could be extracted. 612 
 613 
Figure 5: Meta-analysis for person-to-person transmission. 614 
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The OR for Werber was calculated by combining data, given in the paper, from all age groups 615 
using EpiInfo. * OR was adjusted for possible confounders. “Not estimable” means no data 616 
relevant to this risk-factor could be extracted. 617 
 618 
Figure 6: Funnel plots of studies included in meta-analysis. 619 
A. Funnel plot of studies investigating undercooked or raw meat, with OR plotted against SE. B. 620 
Funnel plot of studies investigating farm visits, with OR plotted against SE. C. Funnel plot of 621 
studies investigating animal contact, with OR plotted against SE. D. Funnel plot of studies 622 
investigating person-to-person transmission, with OR plotted against SE. 623 
 624 
Figure 7: Funnel plots of studies after subgroup analysis. 625 
A. Funnel plot of studies investigating undercooked or raw meat, with OR plotted against SE. B. 626 
Funnel plot of studies investigating farm visits, with OR plotted against SE. C. Funnel plot of 627 
studies investigating animal contact, with OR plotted against SE. D. Funnel plot of studies 628 
investigating person-to-person transmission, with OR plotted against SE. 629 
 630 
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